1. Wylie CE, Collins SN, Verheyen KL, et al. Frequency of equine laminitis: a systematic review with quality appraisal of published evidence. Vet J 2011; 189: 248–256.
2. Garner HE, Coffman JR, Hahn AW, et al. Equine laminitis of alimentary origin: an experimental model. Am J Vet Res 1975; 36: 441–444.
3. Galey FD, Whiteley HE, Goetz TE, et al. Black walnut (Juglans nigra) toxicosis: a model for equine laminitis. J Comp Pathol 1991; 104: 313–326.
4. van Eps AW, Pollitt CC. Equine laminitis induced with oligofructose. Equine Vet J 2006; 38: 203–208.
5. Virgin JE, Goodrich LR, Baxter GM, et al. Incidence of support limb laminitis in horses treated with half limb, full limb or transfixation pin casts: a retrospective study of 113 horses (2000–2009). Equine Vet J Suppl 2011;(40):7–11.
6. Karikoski NP, Horn I, McGowan TW, et al. The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first opinion/referral equine hospital. Domest Anim Endocrinol 2011; 41: 111–117.
7. Donaldson MT, Jorgensen AJ, Beech J. Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis. J Am Vet Med Assoc 2004; 224: 1123–1127.
8. Asplin KE, Patterson-Kane JC, Sillence MN, et al. Histopathology of insulin-induced laminitis in ponies. Equine Vet J 2010; 42: 700–706.
9. de Laat MA, van Eps AW, McGowan CM, et al. Equine laminitis: comparative histopathology 48 hours after experimental induction with insulin or alimentary oligofructose in Standardbred horses. J Comp Pathol 2011; 145: 399–409.
10. McGowan CM, Frost R, Pfeiffer DU, et al. Serum insulin concentrations in horses with equine Cushing's syndrome: response to a cortisol inhibitor and prognostic value. Equine Vet J 2004; 36: 295–298.
11. Frank N, Geor RJ, Bailey SR, et al. Equine metabolic syndrome. J Vet Intern Med 2010; 24: 467–475.
12. McFarlane D. Equine pituitary pars intermedia dysfunction. Vet Clin North Am Equine Pract 2011; 27: 93–113.
13. Pollitt CC. Anatomy and physiology of the inner hoof wall. Clin Tech Equine Pract 2004; 3: 3–21.
14. Wilson A, Weller R. The biomechanics of the equine limb and its effect on lameness. In: Ross MW, Dyson SJ, eds. Diagnosis and management of lameness in the horse. 2nd ed. St Louis: Elsevier Saunders 2011;277.
15. Pollitt CC. Basement membrane pathology: a feature of acute equine laminitis. Equine Vet J 1996; 28: 38–46.
16. Morgan SJ, Hood DM, Wagner IP, et al. Submural histopathologic changes attributable to peracute laminitis in horses. Am J Vet Res 2003; 64: 829–834.
17. French KR, Pollitt CC. Equine laminitis: loss of hemidesmosomes in hoof secondary epidermal lamellae correlates to dose in an oligofructose induction model: an ultrastructural study. Equine Vet J 2004; 36: 230–235.
18. van Eps AW, Pollitt CC. Equine laminitis model: lamellar histopathology seven days after induction with oligofructose. Equine Vet J 2009; 41: 735–740.
19. de Laat MA, Patterson-Kane JC, Pollitt CC, et al. Histological and morphometric lesions in the pre-clinical, developmental phase of insulin-induced laminitis in Standardbred horses. Vet J 2013; 195: 305–312.
20. Kim JA, Montagnani M, Koh KK, et al. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006; 113: 1888–1904.
21. Cusi K, Maezono K, Osman A, et al. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000; 105: 311–320.
22. Buerger C, Richter B, Woth K, et al. Interleukin-1β interferes with epidermal homeostasis through induction of insulin resistance: implications for psoriasis pathogenesis. J Invest Dermatol 2012; 132: 2206–2214.
23. de Laat MA, Pollitt CC, Kyaw-Tanner MT, et al. A potential role for lamellar insulin-like growth factor-1 receptor in the pathogenesis of hyperinsulinaemic laminitis. Vet J 2013; 197: 302–306.
24. Asplin KE, Sillence MN, Pollitt CC, et al. Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies. Vet J 2007; 174: 530–535.
25. National Health and Medical Research Council. Australian code of practice for the care and use of animals for scientific purposes. 7th ed. Canberra, ACT, Australia: National Health and Medical Research Council, Australian Government, 2004.
26. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214–E223.
27. Meyers RK, McGavin MD. Cellular and tissue responses to injury. In: Zachary JF, McGavin MD, eds. Pathologic basis of veterinary disease. 4th ed. St Louis: Mosby Elsevier 2007;16–32.
28. Rudolph P, Knüchel R, Endl E, et al. The immunohistochemical marker Ki-S2: cell cycle kinetics and tissue distribution of a novel proliferation-specific antigen. Mod Pathol 1998; 11: 450–456.
29. Heidebrecht HJ, Buck F, Steinmann J, et al. p100: a novel proliferation-associated nuclear protein specifically restricted to cell cycle phases S, G2, and M. Blood 1997; 90: 226–233.
30. Mayr M, Li C, Zou Y, et al. Biomechanical stress-induced apoptosis in vein grafts involves p38 mitogen-activated protein kinases. FASEB J 2000; 14: 261–270.
31. Greenhalgh DG. The role of apoptosis in wound healing. Int J Biochem Cell Biol 1998; 30: 1019–1030.
32. Hood DM, Wagner IP, Taylor DD, et al. Voluntary limb-load distribution in horses with acute and chronic laminitis. Am J Vet Res 2001; 62: 1393–1398.
33. Nguyen HT, Hsieh MH, Gaborro A, et al. JNK/SAPK and p38 SAPK-2 mediate mechanical stretch-induced apoptosis via caspase-3 and -9 in NRK-52E renal epithelial cells. Nephron Exp Nephrol 2006; 102: 49–61.
34. Ning QM, Sun XN, Zhao XK. Role of mechanical stretching and lipopolysaccharide in early apoptosis and IL-8 of alveolar epithelial type II cells A549. Asian Pac J Trop Med 2012; 5: 638–644.
35. Goodman SA, May SA, Heinegård D, et al. Tenocyte response to cyclical strain and transforming growth factor beta is dependent upon age and site of origin. Biorheology 2004; 41: 613–628.
36. Chicurel ME, Chen CS, Ingber DE. Cellular control lies in the balance of forces. Curr Opin Cell Biol 1998; 10: 232–239.
Advertisement
Objective—To determine cellular changes associated with secondary epidermal laminae (SEL) in forefeet and hind feet of ponies with insulin-induced laminitis.
Animals—8 ponies.
Procedures—Laminitis was induced in 4 ponies by IV administration of insulin and glucose; 4 control ponies received saline (0.9% NaCl) solution IV. Laminar tissue samples obtained from the dorsal aspects of the hooves were histologically evaluated. Primary epidermal lamina (PEL) length and width and SEL length, width, and angle were determined. Numbers of epidermal cell nuclei per micrometer and per total length of SEL and numbers of apoptotic and proliferative cells in axial, middle, and abaxial laminar regions were determined.
Results—SEL in treatment group ponies were significantly longer, were significantly narrower, and had a smaller angle relative to PEL in all laminar regions versus control ponies. In treatment group ponies, the number of epidermal cell nuclei per SEL was typically higher and the number of cells per micrometer of SEL was lower in laminar regions, apoptotic cell numbers were higher in abaxial and middle regions in forefeet and hind feet, and proliferating cell numbers were higher in axial laminar regions in forefeet and all laminar regions in hind feet, versus control ponies.
Conclusions and Clinical Relevance—Results indicated SEL elongation, narrowing, and alteration in orientation developed in all feet of ponies with insulin-induced laminitis. This was primarily attributable to cell stretching that developed at the same time as an accelerated cell death–proliferation cycle; differences in cell cycle responses among laminar regions between forefeet and hind feet may have been attributable to differences in load bearing.
Dr. Asplin's present address is School of Agricultural and Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW 2678, Australia. Dr C. McGowan's present address is Institute of Ageing and Chronic Disease, Faculty of Health and Life Sciences, University of Liverpool, Leahurst CH64 7TE, England. Experiments with horses were conducted at the University of Queensland, Australia.
Supported in part by the Finnish Foundation of Veterinary Research and Erkki Rajakoski Foundation.